Multi-technique hybrid imaging in PET/CT and PET/MR: what does the future hold?

被引:9
作者
Barbosa, E. de Galiza [1 ,2 ]
Delso, G. [1 ,3 ]
ter Voert, E. E. G. W. [1 ,2 ]
Huellner, M. W. [1 ,2 ,4 ]
Herrmann, K. [5 ,6 ]
Veit-Haibach, R. [1 ,2 ,7 ]
机构
[1] Univ Zurich Hosp, Dept Nucl Med, CH-8091 Zurich, Switzerland
[2] Univ Zurich, CH-8006 Zurich, Switzerland
[3] GE Healthcare, Waukesha, WI USA
[4] Univ Zurich Hosp, Dept Neuroradiol, CH-8091 Zurich, Switzerland
[5] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA
[6] Univ Klinikum Wurzburg, Dept Nucl Med, Oberdurrbacher Str 6, Wurzburg, Germany
[7] Univ Zurich Hosp, Dept Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland
关键词
RECEPTOR RADIONUCLIDE THERAPY; POSITRON-EMISSION-TOMOGRAPHY; OF-FLIGHT PET; GA-68-LABELED PSMA LIGAND; RESPONSE ASSESSMENT; CXCR4; EXPRESSION; BRAIN-TUMOR; ATTENUATION CORRECTION; NEUROENDOCRINE TUMORS; INITIAL-EXPERIENCE;
D O I
10.1016/j.crad.2016.03.013
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Integrated positron-emission tomography and computed tomography (PET/CT) is one of the most important imaging techniques to have emerged in oncological practice in the last decade. Hybrid imaging, in general, remains a rapidly growing field, not only in developing countries, but also in western industrialised healthcare systems. A great deal of technological development and research is focused on improving hybrid imaging technology further and introducing new techniques, e.g., integrated PET and magnetic resonance imaging (PET/MRI). Additionally, there are several new PET tracers on the horizon, which have the potential to broaden clinical applications in hybrid imaging for diagnosis as well as therapy. This article aims to highlight some of the major technical and clinical advances that are currently taking place in PET/CT and PET/MRI that will potentially maintain the position of hybrid techniques at the forefront of medical imaging technologies. (C) 2016 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:660 / 672
页数:13
相关论文
共 95 条
[1]   Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience [J].
Afshar-Oromieh, A. ;
Haberkorn, U. ;
Schlemmer, H. P. ;
Fenchel, M. ;
Eder, M. ;
Eisenhut, M. ;
Hadaschik, B. A. ;
Kopp-Schneider, A. ;
Roethke, M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (05) :887-897
[2]   The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer [J].
Afshar-Oromieh, Ali ;
Avtzi, Eleni ;
Giesel, Frederik L. ;
Holland-Letz, Tim ;
Linhart, Heinz G. ;
Eder, Matthias ;
Eisenhut, Michael ;
Boxler, Silvan ;
Hadaschik, Boris A. ;
Kratochwil, Clemens ;
Weichert, Wilko ;
Kopka, Klaus ;
Debus, Juergen ;
Haberkorn, Uwe .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (02) :197-209
[3]  
Alenezi A., 2015, Annals of the ICRP, V44, P259, DOI 10.1177/0146645314551671
[4]   Quantification of Heterogeneity as a Biomarker in Tumor Imaging: A Systematic Review [J].
Alic, Lejla ;
Niessen, Wiro J. ;
Veenland, Jifke F. .
PLOS ONE, 2014, 9 (10)
[5]  
[Anonymous], 2015, NAT REV CLIN ONCOL, V12, P684, DOI DOI 10.1038/NRCLINONC.2012.181
[6]   Localization of Hidden Insulinomas with 68Ga-DOTA-Exendin-4 PET/CT: A Pilot Study [J].
Antwi, Kwadwo ;
Fani, Melpomeni ;
Nicolas, Guillaume ;
Rottenburger, Christof ;
Heye, Tobias ;
Reubi, Jean Claude ;
Gloor, Beat ;
Christ, Emanuel ;
Wild, Damian .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (07) :1075-1078
[7]   2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial [J].
Bachner, M. ;
Loriot, Y. ;
Gross-Goupil, M. ;
Zucali, P. A. ;
Horwich, A. ;
Germa-Lluch, J. -R. ;
Kollmannsberger, C. ;
Stoiber, F. ;
Flechon, A. ;
Oechsle, K. ;
Gillessen, S. ;
Oldenburg, J. ;
Cohn-Cedermark, G. ;
Daugaard, G. ;
Morelli, F. ;
Sella, A. ;
Harland, S. ;
Kerst, M. ;
Gampe, J. ;
Dittrich, C. ;
Fizazi, K. ;
De Santis, M. .
ANNALS OF ONCOLOGY, 2012, 23 (01) :59-64
[8]   Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group [J].
Barrington, Sally F. ;
Mikhaeel, N. George ;
Kostakoglu, Lale ;
Meignan, Michel ;
Hutchings, Martin ;
Mueeller, Stefan P. ;
Schwartz, Lawrence H. ;
Zucca, Emanuele ;
Fisher, Richard I. ;
Trotman, Judith ;
Hoekstra, Otto S. ;
Hicks, Rodney J. ;
O'Doherty, Michael J. ;
Hustinx, Roland ;
Biggi, Alberto ;
Cheson, Bruce D. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3048-+
[9]   PET/MR in Dementia and Other Neurodegenerative Diseases [J].
Barthel, Henryk ;
Schroeter, Matthias L. ;
Hoffmann, Karl-Titus ;
Sabri, Osama .
SEMINARS IN NUCLEAR MEDICINE, 2015, 45 (03) :224-233
[10]   Radionuclide and hybrid imaging of recurrent prostate cancer [J].
Beer, Ambros J. ;
Eiber, Matthias ;
Souvatzoglou, Michael ;
Schwaiger, Markus ;
Krause, Bernd Joachim .
LANCET ONCOLOGY, 2011, 12 (02) :181-191